跳至主要内容
临床试验/CTRI/2022/07/044036
CTRI/2022/07/044036尚未招募未知

Aminophylline in treatment of acute exacerbation of COPD : ACUTE study(Aminophylline in COPD- utility and Treatment effects)

The Calcutta Medical Research Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patient of documented COPD as per GOLD guidelines, admitted with COPD exacerbation.
  • Persistent hypoxia with PF ratio <200 AND hypercarbia with pCO2 >45 ±respiratory acidosis despite maximal standard therapy for COPD exacerbation 72 hours post hospitalisation

排除标准

  • Known structural or physiological cardiac co morbidity
  • -Any other systemic co morbidity that is known to worsen with aminophylline
  • -Persistent Tachycardia(Heart rate >100/min) with or without rate limiting drugs, wherever indicated.
  • -If patient is on any drug known to interact with aminophylline

研究者

相似试验